iBio, Inc. (IBIO) Social Stream



iBio, Inc. (IBIO): $2.97

0.03 (-1.00%)

POWR Rating

Component Grades

Momentum

F

Stability

F

Sentiment

Quality

F

Add IBIO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#251 of 345

in industry

IBIO INC (IBIO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IBIO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-04 2 $3 $3 $3 $3.91 -23.27%
2021-11-29 2 $3 $1.5 $2.25 $3.91 -42.46%
2022-06-06 2 $2.5 $1.5 $2 $3.91 -48.85%
2022-10-07 2 $37.5 $4.25 $20.875 $3.91 433.89%
2022-10-11 2 $4.5 $4.5 $4.5 $3.91 15.09%
2022-12-21 1 $0.5 $0.5 $0.5 $3.91 -87.21%
2023-02-16 1 $1 $1 $1 $3.91 -74.42%

The Trend in the Analyst Price Target


Over the past 128 days, IBIO's average price target has gone down $20.

IBIO reports an average of 22.09% for its upside potential over the past 57 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-12-21 1 0.5 0.5 0.5 0.451 10.86%
2023-02-16 1 1.0 1.0 1.0 0.750 33.33%

IBIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The Trend in the Broker Recommendations


Over the past 52 weeks, IBIO's average broker recommendation rating worsened by 2.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IBIO as an investment opportunity.

  • In the context of all US stocks, IBIO INC's number of analysts covering the stock is greater than 17.52% of them.
  • In the context of all US stocks, IBIO INC's average analyst price target is higher than 64.34% of them.
  • IBIO INC's variance in analysts' estimates is lower than -218.13% of stocks in the small market cap category.
  • In terms of how IBIO INC fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 196.28% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to IBIO INC are AMPE, VTGN, and CRMD.

Is IBIO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!